| Stereotactic Prostate Radiotherapy With Dose Escalation Focused on the "Dominant Intra-prostatic Lesion" (DIPL) Delineated by Multi-parametric MRI and 68Ga-PSMA PET (Prostate-SIB-PSMA) (NCT05599737) | Centre Leon Berard | 2022-05-24 |
| Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer (NCT04543903) | Alpha Tau Medical LTD. | 2022-05-16 |
| Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC) (NCT04704505) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2022-04-28 |
| Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study (NCT05053152) | NRG Oncology | 2022-04-20 |
| Retzius-sparing Technique in Robotic-assisted Radical Prostatectomy (NCT05224024) | Ankara University | 2022-02-15 |
| Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain (NCT05803096) | Beth Israel Deaconess Medical Center | 2021-12-12 |
| Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer (NCT04943536) | Alessa Therapeutics Inc. | 2021-12-07 |
| Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial (NCT05050084) | NRG Oncology | 2021-12-06 |
| Diet and Physical Activity Intervention for the Prevention of ADT-Induced Metabolic Changes in Patients With Prostate Cancer, TRIPLE-A PILOT Study (NCT04870515) | Fred Hutchinson Cancer Center | 2021-11-04 |
| A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer (NCT05027477) | Profound Medical Inc. | 2021-11-01 |
| Customized TULSA-PRO Ablation Registry (NCT05001477) | Profound Medical Inc. | 2021-10-27 |
| Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion (NCT04976257) | Ryan Kohlbrenner, MD | 2021-10-13 |
| Fluorescent Imaging of Nerves With Illuminare-1 During Surgery (NCT04983862) | Memorial Sloan Kettering Cancer Center | 2021-10-04 |
| A Prospective Study to Evaluate the Impact of Maximal Urethral Length Preservation Technique During Robotic Laparoscopic Prostatectomy on the Stretched Flaccid Penile Length and Continence (NCT05735223) | Larkin Health System | 2021-09-30 |
| 68Ga-PSMA-11 PET in Patients With Prostate Cancer (NCT05197257) | University of Colorado, Denver | 2021-09-29 |
| Neoadjuvant Dietary Intervention in Intermediate Risk Prostate Cancer (NCT04985565) | M.D. Anderson Cancer Center | 2021-08-27 |
| High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma (NCT04945642) | Jonsson Comprehensive Cancer Center | 2021-08-20 |
| Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate Cancer (NCT05055843) | M.D. Anderson Cancer Center | 2021-08-10 |
| An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer (NCT04978675) | M.D. Anderson Cancer Center | 2021-08-04 |
| Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer (NCT05003752) | German Oncology Center, Cyprus | 2021-08-01 |
| Ga-68-PSMA-11 in Men With Prostate Cancer (NCT05744115) | Timothy Hoffman | 2021-07-27 |
| Testing the Effects of Low Dose Apalutamide on Prostate-Specific Antigen (PSA) Levels in Men Scheduled for Removal of the Prostate Gland (NCT04530552) | National Cancer Institute (NCI) | 2021-07-23 |
| Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer (NCT04743934) | Andrew McDonald | 2021-07-02 |
| Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy (NCT04915508) | Jonsson Comprehensive Cancer Center | 2021-06-23 |
| A Behavioral Health Intervention Using Digital Technology in Radiation Therapy for Prostate Cancer Patients (NCT04946214) | University of Miami | 2021-05-26 |
| An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer (NCT04777071) | University of Washington | 2021-05-17 |
| White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA (NCT04519879) | City of Hope Medical Center | 2021-05-10 |
| ERG Protein Expression in Prostatic Adenocarcinoma and Its Clinicopathological Features (NCT04825691) | Assiut University | 2021-05-04 |
| Durvalumab and Olaparib for the Treatment of Prostate Cancer in Men Predicted to Have a High Neoantigen Load (NCT04336943) | University of Washington | 2021-04-13 |
| Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy (NCT04053842) | Glenn Bauman | 2021-02-04 |
| Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial (NCT04513717) | NRG Oncology | 2021-01-21 |
| PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE (NCT05022914) | Azienda Ospedaliero-Universitaria Careggi | 2021-01-19 |
| Gallium Ga 68 DOTA-NeoBOMB1 and Gallium Ga 68 PSMA-R2 PET/MRI in Diagnosing Participants With Recurrent Prostate Cancer (NCT03698370) | Andrei Iagaru | 2020-12-15 |
| Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048) (NCT04486755) | University of Maryland, Baltimore | 2020-11-19 |
| Bariatric Arterial Embolization for Men Starting Hormones for Prostate Cancer (NCT04331717) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2020-11-16 |
| Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial (NCT04624256) | Jonsson Comprehensive Cancer Center | 2020-11-10 |
| Trial of NanoPac Focal Therapy for Prostate Cancer (NCT04221828) | NanOlogy, LLC | 2020-10-20 |
| A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects (NCT04288687) | Abramson Cancer Center at Penn Medicine | 2020-10-19 |
| Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC (NCT04446117) | Exelixis | 2020-10-19 |
| A Study to Establish the Feasibility of Biolen for the Local Delivery of Bicalutamide in Patients With Prostate Cancer (NCT04284761) | Alessa Therapeutics Inc. | 2020-10-11 |
| Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging (NCT04423211) | ECOG-ACRIN Cancer Research Group | 2020-10-08 |
| Prospective Comparison of the Four Biopsy Methods for Prostate Cancer Detection (NCT05589558) | I.M. Sechenov First Moscow State Medical University | 2020-10-01 |
| Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study (NCT04175431) | University of Washington | 2020-09-30 |
| Interest of PET-PSMA Imaging Potentialised by Androgen Blockade in Localized Prostatic Adenocarcinoma (NCT04391556) | Centre Leon Berard | 2020-09-14 |
| PROState Pathway Embedded Comparative Trial (NCT04400656) | Imperial College London | 2020-09-08 |
| Intestinal Microbiota in Prostate Cancer Patients as a Biomarker for Radiation-INduced Toxicity (IMPRINT) (NCT04638049) | University Hospital, Ghent | 2020-08-25 |
| Clinical Trial of Green Tea Catechins in Men on Active Surveillance (NCT04300855) | H. Lee Moffitt Cancer Center and Research Institute | 2020-08-21 |
| Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer (NCT04428203) | Zin W Myint | 2020-08-03 |
| Two TraCer PositROn EmiSSion Tomography ComBination for Efficacy EstimatiOn of Prostate Specific Membrane Antigen Radioligand Therapy in Patients With Metastatic Prostate Cancer (NCT04085991) | Sir Mortimer B. Davis - Jewish General Hospital | 2020-07-31 |
| Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer (NCT03649841) | University of Washington | 2020-06-29 |
| Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors (NCT04126070) | Xiao X. Wei, MD | 2020-05-11 |
| Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer (NCT03999515) | University of Washington | 2020-04-27 |
| Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial (NCT04134260) | NRG Oncology | 2020-04-16 |
| Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0 (NCT04045717) | Universitaire Ziekenhuizen KU Leuven | 2020-04-10 |
| Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer (NCT04399824) | Jonsson Comprehensive Cancer Center | 2020-04-03 |
| Efficacy and Safety Assessment of IRE of Localized Prostate Cancer (NCT04192890) | I.M. Sechenov First Moscow State Medical University | 2020-01-27 |
| A Study To Evaluate Hypofractionated Proton Therapy Or IMRT For Recurrent, Oligometastatic Prostate Cancer (NCT04190446) | Mayo Clinic | 2020-01-06 |
| Development and Evaluation of a Quantitative HP MRI for Clinical Prostate Cancer Exam (NCT04286386) | M.D. Anderson Cancer Center | 2019-12-19 |
| Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer (NCT04049747) | Imperial College London | 2019-12-11 |
| Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery (NCT03899987) | Roswell Park Cancer Institute | 2019-11-29 |
| Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer (NCT03830164) | M.D. Anderson Cancer Center | 2019-11-20 |
| Perioperative Atezolizumab With MVA-BN-Brachyury and PROSTVAC For Intermediate-Risk And High-Risk Localized Prostate Cancer (NCT04020094) | University of Utah | 2019-11-20 |
| Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy (NCT03821246) | David Oh | 2019-10-30 |
| Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring (NCT04037254) | NRG Oncology | 2019-10-08 |
| Mechanisms of Metabolic and Hormone Action on Plaque Formation in Brain and Carotid Vessels in Patients With Prostate Adenocarcinoma (NCT03718338) | University of Washington | 2019-10-08 |
| Active Surveillance for Low Risk Prostate Cancer (NCT04146077) | I.M. Sechenov First Moscow State Medical University | 2019-10-01 |
| Prospective Study on the Role of Radical Prostatectomy in Oligo-metastatic Hormone-sensitive Prostate Cancer in Patients on Androgen Deprivation Therapy (NCT07766486) | Fondazione del Piemonte per l'Oncologia | 2019-09-26 |
| Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer (NCT03796767) | University of Utah | 2019-09-09 |
| Single Dose Radiotherapy (SDRT) With or Without Adjuvant Systemic Therapy for Oligometastatic Prostate Cancer (NCT04031378) | Fundacao Champalimaud | 2019-09-01 |
| Increasing the Dose of Survivorship Care Planning in Improving Care and Outcomes in Prostate Cancer Survivors Receiving Androgen Deprivation Therapy (NCT03860961) | NRG Oncology | 2019-07-26 |
| Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer (NCT04030338) | Memorial Sloan Kettering Cancer Center | 2019-07-19 |
| A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer (NCT04019327) | Memorial Sloan Kettering Cancer Center | 2019-07-11 |
| Defining Recurrent Disease With Axumin™ (NCT03996993) | Cancer Center of Irvine | 2019-07-01 |
| 177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer (NCT03805594) | University of California, San Francisco | 2019-05-10 |
| Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes (NCT03762759) | Emory University | 2019-05-10 |
| Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer (NCT03880422) | Roswell Park Cancer Institute | 2019-05-02 |
| Combination of Entinostat and Enzalutamide in Advanced Prostate Cancer (NCT03829930) | George Washington University | 2019-05-01 |
| Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer (NCT03581500) | M.D. Anderson Cancer Center | 2019-02-06 |
| DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine (NCT06347809) | Mayo Clinic | 2019-01-23 |
| Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer (NCT03739684) | Progenics Pharmaceuticals, Inc. | 2018-11-27 |
| Twice High Dose External Beam Radiotherapy by Image-guided Tomotherapy for Organ-confined Prostate Cancer Treatment Emulating High Dose Radiation (HDR) Brachytherapy (NCT03553212) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2018-10-30 |
| Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer (NCT03361735) | City of Hope Medical Center | 2018-08-29 |
| Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer (NCT03516812) | University of Washington | 2018-08-29 |
| Soy Bread Diet in Improving Immune Function in Participants With Prostate Cancer (NCT03654638) | Ohio State University Comprehensive Cancer Center | 2018-08-15 |
| Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance (NCT03933670) | University of California, San Francisco | 2018-07-18 |
| CyberKnife Dose Escalation Prostate Cancer Trial (NCT03822494) | Crozer-Keystone Health System | 2018-07-12 |
| Initial Experience in Brazilian Single Center With High Intensity Focalized Ultrasound (HIFU) Prostate Cancer Therapy: Morbidity, Oncological and Functional Outcomes. (NCT03255135) | Hospital de Transplante Doutor Euryclides de Jesus Zerbini | 2018-05-31 |
| Prostate Radiotherapy Comparing Moderate and Extreme Hypo-fractionation (PRIME Trial) (NCT03561961) | Tata Memorial Centre | 2018-05-24 |
| Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy (NCT03570827) | Mayo Clinic | 2018-05-14 |
| Efficacy and Safety Assessment of IRE of Localized Prostate Cancer. (NCT03504995) | I.M. Sechenov First Moscow State Medical University | 2018-04-19 |
| Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma (NCT03496844) | University of Arizona | 2018-04-15 |
| 68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer (NCT04050215) | Jonsson Comprehensive Cancer Center | 2018-04-02 |
| Apalutamide in Treating Patients With Prostate Cancer Before Radical Prostatectomy (NCT03412396) | M.D. Anderson Cancer Center | 2018-03-22 |
| Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence (NCT03396874) | University of Michigan | 2018-02-09 |
| Ischemic Heart Disease in Male With Prostate Adenocarcinoma (NCT03474835) | Dnipropetrovsk State Medical Academy | 2018-01-15 |
| Early and Accurate Detection of Prostate Cancer in General Practice (NCT03431753) | Aarhus University Hospital | 2018-01-01 |
| Apalutamide in Treating Patients With Prostate Cancer Who Are in Active Surveillance (NCT02721979) | University of Washington | 2017-11-02 |
| Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI (NCT03404648) | Mayo Clinic | 2017-11-01 |
| Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer (NCT03279250) | M.D. Anderson Cancer Center | 2017-10-13 |
| Hemi-Gland Cryoablation for Prostate Cancer at UCLA (NCT03503643) | Jonsson Comprehensive Cancer Center | 2017-09-14 |